Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2005
08/17/2005CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/17/2005CN1215059C Novel heterocyclic compounds and salts thereof and medicinal use of same
08/17/2005CN1214790C Method for preparing isoxazole substituted composition for treating inflammation
08/16/2005US6930120 Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists
08/16/2005US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
08/16/2005US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals
08/16/2005US6930111 Substituted heterocyclic compounds
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives
08/16/2005CA2347588C An oxazinone used in preparing taxol and process for preparation thereof
08/11/2005WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005WO2005073219A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis
08/11/2005WO2005073217A1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073201A1 Urea derivatives
08/11/2005WO2005073197A1 Derivatives of n-` (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073193A1 Vanilloid receptor ligands and their use in treatments
08/11/2005WO2005073189A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
08/11/2005WO2005072741A1 ((11-oxo-10,11-dihydrodibenzo [b, f] [1, 4] oxazepin-1-yl)oxy) acetic acid derivatives and related compounds as cardiovascular preparations used to treat arteriolosclerosis
08/11/2005WO2005072308A2 Cgrp receptor antagonists
08/11/2005WO2005072132A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
08/11/2005WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof
08/11/2005US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/11/2005US20050176792 2-arylcarbonylamino-4,5,6 or 7-(keto(alkyl))-benzimidazoles; cancer, inflammation, immunological disorders and allergic disorders
08/11/2005US20050176791 5-HT2B receptor antagonists
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide
08/11/2005US20050176729 Indole derivatives useful for the treatment of CNS disorders
08/11/2005US20050176726 Pyrimidine ether derivatives; antiinflammatory; analgesic; antiarthritis; antirheumatic;diseases involving sensory nerve function; 2-((6-(4-((1S)-1-(4-fluorophenyl)ethyl)-1-piperazinyl)-4-pyrimidinyl)oxy)quinoline
08/11/2005US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity
08/11/2005US20050176707 Compositions and methods for inducing cell dedifferentiation
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005DE102004003812A1 Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl substituted heterocycles, processes for their preparation and their use as medicaments
08/11/2005DE102004003428A1 Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel New long-acting beta-2-agonists, and their use as medicaments
08/11/2005CA2554911A1 Urea derivatives
08/11/2005CA2554351A1 Cgrp receptor antagonists
08/11/2005CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
08/10/2005EP1560488A2 Antibacterial agents
08/10/2005EP1383754A4 Process for making taxane derivatives
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653051A Substituted anthranilamides for controlling invertebrate pests
08/10/2005CN1653049A Pesticidal pyridinecarboxamide derivatives
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652775A Peptide deformylase inhibitors
08/10/2005CN1214018C Morpholinones as light stabilizers
08/10/2005CN1213658C Picolinamide derivatives and pest controllers containing same as active ingredient
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927229 Difluorothioacetamides of oxazolidinones as antibacterial agents
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/04/2005WO2005070925A1 Aryl substituted heterocycles, method for production and use thereof as medicaments
08/04/2005WO2005070924A1 Substituted quinolines and their use as mycobacterial inhibitors
08/04/2005WO2005070923A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070908A1 Novel long-working beta-2-agonists and use thereof as medicaments
08/04/2005WO2005070893A2 Azadecalin glucocorticoid receptor modulators
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070890A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005WO2005070420A1 1h-benzimidazol-2-yl-benzamide derivatives and related compounds as itk inhibitors (interleukin-2-inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005WO2005037216A3 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
08/04/2005WO2005037199A3 Pyrazole derivatives as cannabinoid receptor modulators
08/04/2005WO2005032464A3 Phenyl pyrrolidine ether tachykinin receptor antagonists
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171352 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 647